Charles River partners with Magellan Stem Cells on cell therapy
CRL has collaborated with Australian biotechnology firm Magellan Stem Cells to advance the development and clinical progress of Magellan's regenerative medicine candidate, Zelestrocel.
CRL has collaborated with Australian biotechnology firm Magellan Stem Cells to advance the development and clinical progress of Magellan's regenerative medicine candidate, Zelestrocel.